Brooks O'Neil
Stock Analyst at Lake Street
(0.66)
# 4,135
Out of 5,130 analysts
34
Total ratings
29.41%
Success rate
-19.45%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.86 | +107.25% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $21.70 | -44.70% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.40 | +135.29% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.25 | +515.38% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $85.02 | +29.38% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $20.14 | +48.96% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $19.37 | +266.55% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.49 | +300.62% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $46.78 | +17.57% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $22.65 | -20.53% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.28 | +115.52% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.21 | +18.76% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.10 | +96.72% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $28.80 | -9.72% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.49 | +2,153.17% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $30.98 | +311.56% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.86
Upside: +107.25%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $21.70
Upside: -44.70%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.40
Upside: +135.29%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.25
Upside: +515.38%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $85.02
Upside: +29.38%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $20.14
Upside: +48.96%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $19.37
Upside: +266.55%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.49
Upside: +300.62%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $46.78
Upside: +17.57%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $22.65
Upside: -20.53%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $9.28
Upside: +115.52%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.21
Upside: +18.76%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.10
Upside: +96.72%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $28.80
Upside: -9.72%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.49
Upside: +2,153.17%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $30.98
Upside: +311.56%